India, April 1 -- Hyderabad-based Neuland Laboratories [NLL], a global contract development and manufacturing organization (CDMO) specialising in complex APIs, has announced a leadership change. Saharsh Davuluri will assume the role of Chief Executive Officer (CEO) and Managing Director (MD), effective immediately, as the company moves into its next stage of CDMO growth.
Davuluri has been with the company for more than 18 years and will position the CDMO as a premier global API process development and commercial manufacturing specialist. Neuland's recent successes have been built on a growing reputation for scale-up of complex APIs and peptides, and the business has tripled its contract services revenues during the la...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.